Multilineage-Potential Cell Generation via PDGF-AB and Azacitidine
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for generating mammalian stem cells with multilineage potential are inefficient and impractical for large-scale applications, particularly in treating age-related conditions such as bone fractures and joint degeneration, as they often result in inappropriate tissue formation and require high doses of expensive exogenous therapies.
Innovation Solution
A method involving the use of PDGF-AB and Azacitidine to transition mature somatic cells into multilineage-potential cells, including mesenchymal stem cells, which can be differentiated for tissue repair and regeneration, either in vitro or in vivo, facilitating the generation of cells with the ability to regenerate connective tissues like bone, cartilage, and muscle.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If current methods are used to generate mammalian stem cells with multilineage potential, then stem cell therapy can be provided, but the process is inefficient and impractical for large-scale applications
Solution Approach 1:
The invention changes the chemical parameters of the culture medium by adding specific growth factors (bFGF, TGF-beta1, IGF-1) and adjusting their concentrations to optimize stem cell expansion efficiency and maintain multilineage potential, enabling scalable production
2Reliability
If exogenous therapies such as BMP2 are used to promote tissue regeneration, then tissue repair can be achieved, but high doses are required which can give rise to ectopic bone formation
Solution Approach 1:
The invention uses mesenchymal stem cells as intermediary agents that naturally respond to injury and differentiate into bone tissue only where needed, replacing the direct application of BMP2 and eliminating the risk of ectopic bone formation while maintaining effective tissue repair
Solution Approach 2:
The mesenchymal stem cells are activated to self-differentiate and self-organize into functional bone tissue in response to local injury signals, eliminating the need for high-dose exogenous BMP2 and preventing harmful side effects
3Reliability
If resident stem/progenitor cells are activated to repair tissues, then tissue regeneration can occur, but low starting numbers of these cells is a limiting factor
Solution Approach 1:
The invention performs preliminary expansion of mesenchymal stem cells in culture before transplantation, increasing the starting cell number sufficiently to ensure effective tissue regeneration while maintaining the cells' multilineage potential and therapeutic efficacy
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach allows for reliable and efficient generation of multilineage-potential cells that can effectively contribute to tissue repair and regeneration, reducing the need for high-dose exogenous therapies and minimizing inappropriate tissue formation, thereby addressing the limitations of existing stem cell therapies.
Implementation Method 1
contacting a mammalian somatic cell exhibiting a mature phenotype with PDGF-AB or functional derivative, fragment or mimetic thereof and Azacitidine or functional derivative or analogue thereof for a time and under conditions sufficient to induce the transition of said somatic cell to a cell exhibiting multilineage differentiative potential
Data Source
AI summary
The present invention relates to methods for generating mammalian multilineage-potential cells, including mesenchymal stem cells, comprising contacting mammalian somatic cells exhibiting a mature phenotype with PDGF-AB or functional derivative, fragment or mimetic thereof and Azacitidine or functional derivative or analog thereof for a time and under conditions sufficient to induce the transition of the somatic cells to cells exhibiting multilineage differentiative potential. Also provided are uses of said multilineage-potential cells, such as in promoting tissue repair and regeneration.